
1. expert rev vaccines. 2015;14(10):1331-46. doi: 10.1586/14760584.2015.1078732.
epub 2015 sep 7.

efficacy effectiveness live attenuated influenza vaccine school-age
children.

coelingh k(1), olajide ir(2), macdonald p(1), yogev r(3).

author information: 
(1)a 1 medimmune, gaithersburg, md, usa.
(2)b 2 astrazeneca, gaithersburg, md, usa.
(3)c 3 ann & robert lurie children's hospital chicago, chicago, il, usa.

evidence high efficacy live attenuated influenza vaccine (laiv) from
randomized controlled trials strong children 2-6 years age, fewer
data exist older school-age children. reviewed published data on
efficacy effectiveness laiv children â‰¥5 years. quosa (elsevier
database) searched articles published january 1990 june 2014 that
included 'flumist', 'laiv', 'caiv', 'cold adapted influenza vaccine', 'live
attenuated influenza vaccine', 'live attenuated cold adapted' 'flu mist'.
studies evaluated included randomized controlled trials, effectiveness and
indirect protection studies. review demonstrates laiv considerable 
efficacy effectiveness school-age children.

doi: 10.1586/14760584.2015.1078732 
pmid: 26372891  [indexed medline]

